E-Qure Corp.
E-Qure Corp. EQUR Peers
See (EQUR) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EQUR | $0.00 | -99.50% | 6909.00 | -0.01 | -$0.03 | N/A |
| SEMHF | $55.28 | +2.37% | 62.00B | 26.58 | $2.08 | +2.02% |
| SMMNY | $27.64 | -0.41% | 62.00B | 26.58 | $1.04 | +1.21% |
| RYLPF | $24.21 | +0.01% | 22.40B | 83.49 | $0.29 | +3.89% |
| SONVF | $340.94 | N/A | 20.32B | 31.77 | $10.73 | +1.70% |
| SONVY | $67.72 | -0.52% | 20.25B | 31.50 | $2.15 | +1.41% |
| SNNUF | $14.21 | -4.25% | 12.43B | 30.23 | $0.47 | +2.64% |
| CHEOY | $88.66 | -1.17% | 11.60B | 48.98 | $1.81 | +1.59% |
| CHEOF | $175.40 | +3.18% | 11.44B | 48.19 | $3.64 | +1.58% |
| WILYY | $19.25 | N/A | 8.42B | 19.25 | $1.00 | N/A |
Stock Comparison
EQUR vs SEMHF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, SEMHF has a market cap of 62.00B. Regarding current trading prices, EQUR is priced at $0.00, while SEMHF trades at $55.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas SEMHF's P/E ratio is 26.58. In terms of profitability, EQUR's ROE is +1.75%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, EQUR is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs SMMNY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, SMMNY has a market cap of 62.00B. Regarding current trading prices, EQUR is priced at $0.00, while SMMNY trades at $27.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas SMMNY's P/E ratio is 26.58. In terms of profitability, EQUR's ROE is +1.75%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, EQUR is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs RYLPF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, RYLPF has a market cap of 22.40B. Regarding current trading prices, EQUR is priced at $0.00, while RYLPF trades at $24.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas RYLPF's P/E ratio is 83.49. In terms of profitability, EQUR's ROE is +1.75%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, EQUR is less volatile compared to RYLPF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs SONVF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, SONVF has a market cap of 20.32B. Regarding current trading prices, EQUR is priced at $0.00, while SONVF trades at $340.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas SONVF's P/E ratio is 31.77. In terms of profitability, EQUR's ROE is +1.75%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, EQUR is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs SONVY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, SONVY has a market cap of 20.25B. Regarding current trading prices, EQUR is priced at $0.00, while SONVY trades at $67.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas SONVY's P/E ratio is 31.50. In terms of profitability, EQUR's ROE is +1.75%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, EQUR is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs SNNUF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, SNNUF has a market cap of 12.43B. Regarding current trading prices, EQUR is priced at $0.00, while SNNUF trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas SNNUF's P/E ratio is 30.23. In terms of profitability, EQUR's ROE is +1.75%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, EQUR and SNNUF have similar daily volatility (0.00).
EQUR vs CHEOY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, CHEOY has a market cap of 11.60B. Regarding current trading prices, EQUR is priced at $0.00, while CHEOY trades at $88.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas CHEOY's P/E ratio is 48.98. In terms of profitability, EQUR's ROE is +1.75%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, EQUR is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs CHEOF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, CHEOF has a market cap of 11.44B. Regarding current trading prices, EQUR is priced at $0.00, while CHEOF trades at $175.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas CHEOF's P/E ratio is 48.19. In terms of profitability, EQUR's ROE is +1.75%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, EQUR is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs WILYY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, WILYY has a market cap of 8.42B. Regarding current trading prices, EQUR is priced at $0.00, while WILYY trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas WILYY's P/E ratio is 19.25. In terms of profitability, EQUR's ROE is +1.75%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, EQUR and WILYY have similar daily volatility (0.00).
EQUR vs WILLF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, WILLF has a market cap of 7.86B. Regarding current trading prices, EQUR is priced at $0.00, while WILLF trades at $38.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas WILLF's P/E ratio is 19.11. In terms of profitability, EQUR's ROE is +1.75%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, EQUR is less volatile compared to WILLF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs GNGBY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, GNGBY has a market cap of 5.48B. Regarding current trading prices, EQUR is priced at $0.00, while GNGBY trades at $20.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas GNGBY's P/E ratio is 35.76. In terms of profitability, EQUR's ROE is +1.75%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, EQUR is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs GNGBF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, EQUR is priced at $0.00, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, EQUR's ROE is +1.75%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, EQUR is less volatile compared to GNGBF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs AMBBY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, AMBBY has a market cap of 4.20B. Regarding current trading prices, EQUR is priced at $0.00, while AMBBY trades at $15.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas AMBBY's P/E ratio is 75.05. In terms of profitability, EQUR's ROE is +1.75%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, EQUR and AMBBY have similar daily volatility (0.00).
EQUR vs AMBFF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, AMBFF has a market cap of 4.02B. Regarding current trading prices, EQUR is priced at $0.00, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, EQUR's ROE is +1.75%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, EQUR is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs NHNKY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, NHNKY has a market cap of 3.96B. Regarding current trading prices, EQUR is priced at $0.00, while NHNKY trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas NHNKY's P/E ratio is 20.75. In terms of profitability, EQUR's ROE is +1.75%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, EQUR is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs NHNKF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, NHNKF has a market cap of 2.46B. Regarding current trading prices, EQUR is priced at $0.00, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, EQUR's ROE is +1.75%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, EQUR and NHNKF have similar daily volatility (0.00).
EQUR vs VTRLY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, EQUR is priced at $0.00, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, EQUR's ROE is +1.75%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, EQUR and VTRLY have similar daily volatility (0.00).
EQUR vs STSEY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, EQUR is priced at $0.00, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas STSEY's P/E ratio is 39.41. In terms of profitability, EQUR's ROE is +1.75%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, EQUR and STSEY have similar daily volatility (0.00).
EQUR vs GNNDY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, GNNDY has a market cap of 2.02B. Regarding current trading prices, EQUR is priced at $0.00, while GNNDY trades at $41.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas GNNDY's P/E ratio is 16.81. In terms of profitability, EQUR's ROE is +1.75%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, EQUR is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs GGNDF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, GGNDF has a market cap of 1.89B. Regarding current trading prices, EQUR is priced at $0.00, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas GGNDF's P/E ratio is 15.66. In terms of profitability, EQUR's ROE is +1.75%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, EQUR is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs OSSFF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, EQUR is priced at $0.00, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, EQUR's ROE is +1.75%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, EQUR is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs DWRKF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, EQUR is priced at $0.00, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, EQUR's ROE is +1.75%, compared to DWRKF's ROE of N/A. Regarding short-term risk, EQUR and DWRKF have similar daily volatility (0.00).
EQUR vs SSII Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, SSII has a market cap of 1.74B. Regarding current trading prices, EQUR is priced at $0.00, while SSII trades at $8.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas SSII's P/E ratio is -112.12. In terms of profitability, EQUR's ROE is +1.75%, compared to SSII's ROE of -1.33%. Regarding short-term risk, EQUR is less volatile compared to SSII. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs MCRPF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, EQUR is priced at $0.00, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, EQUR's ROE is +1.75%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, EQUR is less volatile compared to MCRPF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs OSSUY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, EQUR is priced at $0.00, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, EQUR's ROE is +1.75%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, EQUR and OSSUY have similar daily volatility (0.00).
EQUR vs MEDGF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, EQUR is priced at $0.00, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, EQUR's ROE is +1.75%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, EQUR and MEDGF have similar daily volatility (0.00).
EQUR vs DRWKF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, DRWKF has a market cap of 1.20B. Regarding current trading prices, EQUR is priced at $0.00, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas DRWKF's P/E ratio is 9.10. In terms of profitability, EQUR's ROE is +1.75%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, EQUR is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs DGWPF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, DGWPF has a market cap of 1.18B. Regarding current trading prices, EQUR is priced at $0.00, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas DGWPF's P/E ratio is 7.72. In terms of profitability, EQUR's ROE is +1.75%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, EQUR is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs XVIPF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, EQUR is priced at $0.00, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas XVIPF's P/E ratio is 74.77. In terms of profitability, EQUR's ROE is +1.75%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, EQUR and XVIPF have similar daily volatility (0.00).
EQUR vs LFTSF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, EQUR is priced at $0.00, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, EQUR's ROE is +1.75%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, EQUR and LFTSF have similar daily volatility (0.00).
EQUR vs ELEAF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, ELEAF has a market cap of 832.49M. Regarding current trading prices, EQUR is priced at $0.00, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas ELEAF's P/E ratio is 12.22. In terms of profitability, EQUR's ROE is +1.75%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, EQUR is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs MDRSF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, EQUR is priced at $0.00, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, EQUR's ROE is +1.75%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, EQUR is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs CALZF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, CALZF has a market cap of 615.54M. Regarding current trading prices, EQUR is priced at $0.00, while CALZF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas CALZF's P/E ratio is 89.10. In terms of profitability, EQUR's ROE is +1.75%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, EQUR is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs AVMR Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, EQUR is priced at $0.00, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas AVMR's P/E ratio is -18.34. In terms of profitability, EQUR's ROE is +1.75%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, EQUR and AVMR have similar daily volatility (0.00).
EQUR vs CLVSF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, EQUR is priced at $0.00, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, EQUR's ROE is +1.75%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, EQUR is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs IOBCF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, IOBCF has a market cap of 388.16M. Regarding current trading prices, EQUR is priced at $0.00, while IOBCF trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas IOBCF's P/E ratio is 37.86. In terms of profitability, EQUR's ROE is +1.75%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, EQUR is less volatile compared to IOBCF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs HYBT Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, EQUR is priced at $0.00, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas HYBT's P/E ratio is N/A. In terms of profitability, EQUR's ROE is +1.75%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, EQUR and HYBT have similar daily volatility (0.00).
EQUR vs EAPIF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, EQUR is priced at $0.00, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas EAPIF's P/E ratio is -1.98. In terms of profitability, EQUR's ROE is +1.75%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, EQUR is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs CSSPF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, EQUR is priced at $0.00, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, EQUR's ROE is +1.75%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, EQUR is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs CYBQY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, CYBQY has a market cap of 258.06M. Regarding current trading prices, EQUR is priced at $0.00, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas CYBQY's P/E ratio is -40.67. In terms of profitability, EQUR's ROE is +1.75%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, EQUR is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs SNWV Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, SNWV has a market cap of 257.44M. Regarding current trading prices, EQUR is priced at $0.00, while SNWV trades at $30.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas SNWV's P/E ratio is -4.83. In terms of profitability, EQUR's ROE is +1.75%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, EQUR is less volatile compared to SNWV. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs CLLKF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, CLLKF has a market cap of 253.16M. Regarding current trading prices, EQUR is priced at $0.00, while CLLKF trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas CLLKF's P/E ratio is -8.14. In terms of profitability, EQUR's ROE is +1.75%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, EQUR is less volatile compared to CLLKF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs HTLZF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, EQUR is priced at $0.00, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, EQUR's ROE is +1.75%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, EQUR and HTLZF have similar daily volatility (0.00).
EQUR vs BCCOY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, BCCOY has a market cap of 221.04M. Regarding current trading prices, EQUR is priced at $0.00, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, EQUR's ROE is +1.75%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, EQUR is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs IMPZY Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, EQUR is priced at $0.00, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, EQUR's ROE is +1.75%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, EQUR and IMPZY have similar daily volatility (0.00).
EQUR vs AVHHL Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, AVHHL has a market cap of 176.38M. Regarding current trading prices, EQUR is priced at $0.00, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, EQUR's ROE is +1.75%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, EQUR and AVHHL have similar daily volatility (0.00).
EQUR vs CYBQF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, EQUR is priced at $0.00, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas CYBQF's P/E ratio is -43.33. In terms of profitability, EQUR's ROE is +1.75%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, EQUR and CYBQF have similar daily volatility (0.00).
EQUR vs BRNHF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, EQUR is priced at $0.00, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, EQUR's ROE is +1.75%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, EQUR is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs EKDHF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, EKDHF has a market cap of 161.81M. Regarding current trading prices, EQUR is priced at $0.00, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, EQUR's ROE is +1.75%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, EQUR is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs JMDMF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, JMDMF has a market cap of 151.31M. Regarding current trading prices, EQUR is priced at $0.00, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, EQUR's ROE is +1.75%, compared to JMDMF's ROE of N/A. Regarding short-term risk, EQUR is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs PXMBF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, PXMBF has a market cap of 142.82M. Regarding current trading prices, EQUR is priced at $0.00, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, EQUR's ROE is +1.75%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, EQUR and PXMBF have similar daily volatility (0.00).
EQUR vs BRSYF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, EQUR is priced at $0.00, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, EQUR's ROE is +1.75%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, EQUR is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs AMEUF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, EQUR is priced at $0.00, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, EQUR's ROE is +1.75%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, EQUR is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs VMTHF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, EQUR is priced at $0.00, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, EQUR's ROE is +1.75%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, EQUR is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs FDMDF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, EQUR is priced at $0.00, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, EQUR's ROE is +1.75%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, EQUR and FDMDF have similar daily volatility (0.00).
EQUR vs RSHUF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, EQUR is priced at $0.00, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, EQUR's ROE is +1.75%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, EQUR is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs CKMTF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, EQUR is priced at $0.00, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, EQUR's ROE is +1.75%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, EQUR and CKMTF have similar daily volatility (0.00).
EQUR vs SOMNF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, EQUR is priced at $0.00, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, EQUR's ROE is +1.75%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, EQUR is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs DMTRF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, EQUR is priced at $0.00, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, EQUR's ROE is +1.75%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, EQUR is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs IPDQF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, IPDQF has a market cap of 75.83M. Regarding current trading prices, EQUR is priced at $0.00, while IPDQF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas IPDQF's P/E ratio is -3.74. In terms of profitability, EQUR's ROE is +1.75%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, EQUR is less volatile compared to IPDQF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs SNZZF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, EQUR is priced at $0.00, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, EQUR's ROE is +1.75%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, EQUR is less volatile compared to SNZZF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs RDGL Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, RDGL has a market cap of 56.12M. Regarding current trading prices, EQUR is priced at $0.00, while RDGL trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas RDGL's P/E ratio is -12.37. In terms of profitability, EQUR's ROE is +1.75%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, EQUR is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs BLOZF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, BLOZF has a market cap of 49.51M. Regarding current trading prices, EQUR is priced at $0.00, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas BLOZF's P/E ratio is -21.50. In terms of profitability, EQUR's ROE is +1.75%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, EQUR is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs NVYTF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, EQUR is priced at $0.00, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas NVYTF's P/E ratio is -0.78. In terms of profitability, EQUR's ROE is +1.75%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, EQUR is less volatile compared to NVYTF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs TLTFF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, TLTFF has a market cap of 32.14M. Regarding current trading prices, EQUR is priced at $0.00, while TLTFF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas TLTFF's P/E ratio is -12.97. In terms of profitability, EQUR's ROE is +1.75%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, EQUR is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs ELXMF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, EQUR is priced at $0.00, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, EQUR's ROE is +1.75%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, EQUR and ELXMF have similar daily volatility (0.00).
EQUR vs PYNKF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, PYNKF has a market cap of 28.32M. Regarding current trading prices, EQUR is priced at $0.00, while PYNKF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas PYNKF's P/E ratio is -1.68. In terms of profitability, EQUR's ROE is +1.75%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, EQUR and PYNKF have similar daily volatility (0.00).
EQUR vs KBBTF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, EQUR is priced at $0.00, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, EQUR's ROE is +1.75%, compared to KBBTF's ROE of N/A. Regarding short-term risk, EQUR and KBBTF have similar daily volatility (0.00).
EQUR vs EMITF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, EQUR is priced at $0.00, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas EMITF's P/E ratio is -15.38. In terms of profitability, EQUR's ROE is +1.75%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, EQUR is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs POSC Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, POSC has a market cap of 21.16M. Regarding current trading prices, EQUR is priced at $0.00, while POSC trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas POSC's P/E ratio is 0.44. In terms of profitability, EQUR's ROE is +1.75%, compared to POSC's ROE of +9.25%. Regarding short-term risk, EQUR is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs ASAPF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, ASAPF has a market cap of 18.06M. Regarding current trading prices, EQUR is priced at $0.00, while ASAPF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas ASAPF's P/E ratio is -23.39. In terms of profitability, EQUR's ROE is +1.75%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, EQUR is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs VPTDF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, VPTDF has a market cap of 14.46M. Regarding current trading prices, EQUR is priced at $0.00, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas VPTDF's P/E ratio is -4.43. In terms of profitability, EQUR's ROE is +1.75%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, EQUR is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs MDXHF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, MDXHF has a market cap of 14.31M. Regarding current trading prices, EQUR is priced at $0.00, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, EQUR's ROE is +1.75%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, EQUR and MDXHF have similar daily volatility (0.00).
EQUR vs TMDIF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, TMDIF has a market cap of 13.91M. Regarding current trading prices, EQUR is priced at $0.00, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, EQUR's ROE is +1.75%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, EQUR is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs DIZTF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, DIZTF has a market cap of 13.69M. Regarding current trading prices, EQUR is priced at $0.00, while DIZTF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas DIZTF's P/E ratio is -5.67. In terms of profitability, EQUR's ROE is +1.75%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, EQUR is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs PLLWF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, EQUR is priced at $0.00, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, EQUR's ROE is +1.75%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, EQUR is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs RMSL Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, RMSL has a market cap of 12.28M. Regarding current trading prices, EQUR is priced at $0.00, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas RMSL's P/E ratio is 0.80. In terms of profitability, EQUR's ROE is +1.75%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, EQUR is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs IMEXF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, IMEXF has a market cap of 11.62M. Regarding current trading prices, EQUR is priced at $0.00, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas IMEXF's P/E ratio is N/A. In terms of profitability, EQUR's ROE is +1.75%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, EQUR is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs ATBPF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, EQUR is priced at $0.00, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, EQUR's ROE is +1.75%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, EQUR is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs LXXGF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, EQUR is priced at $0.00, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, EQUR's ROE is +1.75%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, EQUR and LXXGF have similar daily volatility (0.00).
EQUR vs GTHP Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, GTHP has a market cap of 9.86M. Regarding current trading prices, EQUR is priced at $0.00, while GTHP trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas GTHP's P/E ratio is -2.50. In terms of profitability, EQUR's ROE is +1.75%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, EQUR is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs IRME Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, IRME has a market cap of 8.64M. Regarding current trading prices, EQUR is priced at $0.00, while IRME trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas IRME's P/E ratio is -4.00. In terms of profitability, EQUR's ROE is +1.75%, compared to IRME's ROE of +11.77%. Regarding short-term risk, EQUR is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs MKEAF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, MKEAF has a market cap of 6.43M. Regarding current trading prices, EQUR is priced at $0.00, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, EQUR's ROE is +1.75%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, EQUR and MKEAF have similar daily volatility (0.00).
EQUR vs DTXMF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, EQUR is priced at $0.00, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, EQUR's ROE is +1.75%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, EQUR is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs TBRIF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, TBRIF has a market cap of 5.64M. Regarding current trading prices, EQUR is priced at $0.00, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas TBRIF's P/E ratio is -1.24. In terms of profitability, EQUR's ROE is +1.75%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, EQUR is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs QLIS Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, EQUR is priced at $0.00, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas QLIS's P/E ratio is 2.22. In terms of profitability, EQUR's ROE is +1.75%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, EQUR and QLIS have similar daily volatility (0.00).
EQUR vs RHNMF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, EQUR is priced at $0.00, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, EQUR's ROE is +1.75%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, EQUR is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs MICR Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, EQUR is priced at $0.00, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas MICR's P/E ratio is -3.47. In terms of profitability, EQUR's ROE is +1.75%, compared to MICR's ROE of -0.25%. Regarding short-term risk, EQUR is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs FZMD Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, FZMD has a market cap of 4.43M. Regarding current trading prices, EQUR is priced at $0.00, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas FZMD's P/E ratio is 1.20. In terms of profitability, EQUR's ROE is +1.75%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, EQUR is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs NUMD Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, NUMD has a market cap of 4.18M. Regarding current trading prices, EQUR is priced at $0.00, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas NUMD's P/E ratio is 5.00. In terms of profitability, EQUR's ROE is +1.75%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, EQUR and NUMD have similar daily volatility (0.00).
EQUR vs LBLTF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, EQUR is priced at $0.00, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, EQUR's ROE is +1.75%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, EQUR is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs ADMT Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, ADMT has a market cap of 4.06M. Regarding current trading prices, EQUR is priced at $0.00, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas ADMT's P/E ratio is -6.00. In terms of profitability, EQUR's ROE is +1.75%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, EQUR is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs VYCO Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, VYCO has a market cap of 4.00M. Regarding current trading prices, EQUR is priced at $0.00, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas VYCO's P/E ratio is -12.00. In terms of profitability, EQUR's ROE is +1.75%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, EQUR is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs ALRTF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, ALRTF has a market cap of 3.81M. Regarding current trading prices, EQUR is priced at $0.00, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas ALRTF's P/E ratio is -0.20. In terms of profitability, EQUR's ROE is +1.75%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, EQUR and ALRTF have similar daily volatility (0.00).
EQUR vs VANIW Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, EQUR is priced at $0.00, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas VANIW's P/E ratio is N/A. In terms of profitability, EQUR's ROE is +1.75%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, EQUR is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs ESMC Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, ESMC has a market cap of 3.34M. Regarding current trading prices, EQUR is priced at $0.00, while ESMC trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas ESMC's P/E ratio is 45.00. In terms of profitability, EQUR's ROE is +1.75%, compared to ESMC's ROE of +0.47%. Regarding short-term risk, EQUR is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs USAQ Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, USAQ has a market cap of 2.93M. Regarding current trading prices, EQUR is priced at $0.00, while USAQ trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas USAQ's P/E ratio is -8.67. In terms of profitability, EQUR's ROE is +1.75%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, EQUR is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs BIEL Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, BIEL has a market cap of 2.71M. Regarding current trading prices, EQUR is priced at $0.00, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas BIEL's P/E ratio is N/A. In terms of profitability, EQUR's ROE is +1.75%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, EQUR is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.
EQUR vs PMEDF Comparison
EQUR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EQUR stands at 6909.00. In comparison, PMEDF has a market cap of 2.25M. Regarding current trading prices, EQUR is priced at $0.00, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EQUR currently has a P/E ratio of -0.01, whereas PMEDF's P/E ratio is -1.50. In terms of profitability, EQUR's ROE is +1.75%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, EQUR is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for EQUR.